Amneal Pharmaceuticals Ratios (2017-2026) | AMRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	39.71%	37.55%	30.99%	6,019.69%	35.85%	35.60%	-13.61%	31.96%	36.73%	37.50%	30.77%	36.11%	35.62%	38.37%	35.98%	36.80%	39.51%	34.92%	36.50%	44.31%
EBT Margin (Quarter)	6.51%	-0.39%	-3.04%	-342.10%	-41.61%	0.40%	0.48%	-1.69%	4.95%	3.70%	-13.53%	-11.46%	2.91%	2.20%	-2.10%	5.39%	7.14%	-0.67%	6.78%	11.10%
EBIT Margin (Quarter)	12.54%	5.39%	2.08%	803.62%	-35.51%	8.13%	-2.28%	6.18%	13.37%	12.20%	2.30%	-1.63%	13.60%	12.64%	10.38%	14.43%	15.37%	8.97%	13.76%	19.62%
EBITDA Margin (Quarter)	12.54%	5.39%	2.08%	803.62%	-35.51%	8.13%	-2.28%	6.18%	13.37%	12.20%	2.30%	-1.63%	13.60%	12.64%	10.38%	14.43%	15.37%	8.97%	13.76%	19.62%
Operating Margin (Quarter)	12.54%	5.39%	2.08%	803.62%	-35.51%	8.13%	-2.28%	6.18%	13.37%	12.20%	2.30%	-1.63%	13.60%	12.64%	10.38%	14.43%	15.37%	8.97%	13.76%	19.62%
Net Margin (Quarter)	2.72%	-0.80%	-1.19%	-74.34%	-21.60%	-0.49%	0.27%	-1.25%	1.99%	1.56%	-15.99%	-12.39%	2.39%	1.67%	-2.84%	3.54%	4.92%	2.31%	6.09%	10.80%
FCF Margin (Quarter)	-11.17%	13.57%	8.52%	3,777.59%	-23.34%	13.65%	2.20%	23.32%	-3.90%	11.25%	20.42%	-2.06%	4.14%	17.77%	14.09%	-0.83%	8.42%	13.53%	13.33%	-4.83%
Efficiency
Inventory Average (Quarter)	510.20M	521.82M	504.82M	500.81M	522.63M	538.44M	537.30M	529.89M	539.80M	563.52M	578.93M	576.02M	573.14M	585.99M	604.41M	606.94M	605.20M	611.74M	610.40M	623.96M
Assets Average (Quarter)	3,991.56M	3,998.73M	3,957.04M	3,914.32M	3,965.19M	3,957.72M	3,836.69M	3,712.97M	3,663.75M	3,693.98M	3,579.82M	3,464.48M	3,483.16M	3,485.45M	3,481.21M	3,433.35M	3,394.02M	3,511.33M	3,639.08M	3,609.25M
Equity Average (Quarter)	378.49M	386.72M	375.07M	387.19M	290.20M	183.64M	189.13M	159.32M	142.72M	152.50M	87.12M	-21.81M	-60.56M	-75.53M	-101.54M	-120.76M	-122.27M	-111.24M	-90.37M	-58.10M
Invested Capital (Quarter)	427.27M	421.17M	3,077.64M	445.71M	2,825.36M	2,831.45M	248.24M	2,726.36M	2,730.35M	2,726.58M	2,440.14M	2,347.74M	2,345.24M	2,300.73M	-49.41M	2,053.77M	2,065.05M	2,463.75M	2,501.08M	2,526.35M
Asset Utilization Ratio (Quarter)	0.09	0.10	0.53	0.41	0.41	0.42	-0.12	0.02	0.03	0.05	0.67	0.72	0.75	0.77	0.80	0.82	0.84	0.84	0.83	0.84
Leverage & Solvency
Debt to Equity (Quarter)	7.05	0.18	0.19	0.17	0.40	0.51	14.41	19.13	17.11	16.97	120.94	-40.18	-40.99	-24.68	-21.79	-16.56	-21.65	-23.41	-36.33	-56.63
Debt Ratio (Quarter)	0.68	0.02	0.02	0.02	0.02	0.03	0.70	0.71	0.70	0.71	0.70	0.74	0.67	0.67	0.68	0.65	0.71	0.71	0.70	0.73
Equity Ratio (Quarter)	0.10	0.10	0.09	0.10	0.04	0.05	0.05	0.04	0.04	0.04	0.01	-0.02	-0.02	-0.03	-0.03	-0.04	-0.03	-0.03	-0.02	-0.01
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-264.19M	7.30M	7.96M	-194.06M	11.68M	13.82M	-1.03M	21.13M	-77.18M	-49.78M	33.73M	41.92M	9.65M	55.55M	57.07M	66.03M	-5.74M	33.05M	-282.56M	-4.73M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	-0.02%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	1.47%	2.25%	4.66%	3.93%	-4.56%	-3.82%	-3.08%	-2.78%	6.75%	7.71%	7.48%	6.05%	7.37%	7.85%	10.60%	15.29%	16.46%	13.51%	14.29%	15.12%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.02%	0.00%	0.00%	-0.01%	0.06%	0.02%	0.02%	0.01%	0.00%	0.00%	-0.01%	-0.01%	-0.03%

Research Tools

Amneal Pharmaceuticals Ratios (2017-2026) | AMRX

Create an account

Sign In

Reset Password